Close Menu

genomics

The company is in the late stages of closing a Series D investment, but due to the slowdown of the capital markets in recent months, "it has taken us longer than anticipated to close," a company official said.

After going through a restructuring phase at the end of last year in which it temporarily laid off its entire staff, LightSpeed continues to develop its optical detection technology and plans to test it with a new sequencing chemistry this year.

In Print: Apr 14, 2009

Premium

Microarray-Related Papers of Note Published in March 2009

Frank Witney, Paul Keim, Trilochan Sahoo, Jack Lord, Mari Baker, Patrick Terry, Lutz Kirchrath

NextBio will use the funds to develop its vertebrate and plant information platform for cross-species research.

The merger will combine Eureka's bioinformatics capabilities with Nanobac's drug discovery program focused on inhibiting, destroying, or neutralizing calcifying nanoparticles.

Some of NIH's and NHGRI's challenge grants will give priorities to ethical issues that confront genomics, pharmacogenomics, and biomedicine.

Verdezyne will optimize selected genes that encode industrial enzymes for Novozymes.

Complete Genomics has been forced to cut staff salaries and take other cost-saving steps as its Series D financing round has been delayed in closing.

Developing high-throughput technologies, personalized medicine, and data handling tools are the focus of the NIH/NHGRI challenge grants.

Pages

Nature News reports that genomics is being applied to trace and try to prevent additional COVID-19 waves.

Rady's Children Hospital and San Diego County are teaming up to test pediatric patients and their families for COVID-19 to gauge the spread of the virus locally, according to the San Diego Union-Tribune.

Wildlife managers aim to boost the genetic diversity of Mexican gray wolves by placing captive-born foster pups into packs with similarly aged wild pups, the Mercury News reports.

In Science this week: Genetic Probability tool identifies likely diagnoses in 45 percent of inflammatory arthritis cases, and more.